FOLLOW US :
  • |
  • |

Equity

Daily Market Tracker
Market Analysis
Other Markets
Corporate Actions
News
Corporate Information

Key Financial Ratios Home > Equity > Corporate Information > Key Financial Ratios

Influx Healthtech LtdIndustry : Pharmaceuticals - Indian - Formulations
BSE Code:93847 P/E (TTM) :27.29
ISIN Demat:INE0MYZ01012 Div & Yield %:0 EPS (TTM) :5.77
Book Value (RS) :36.3489357 Market Cap (Rs Cr.):364.5 Face Value (RS) :10
    Change Company 
YearsMar 2025Mar 2024Mar 2023Mar 2022
Debt-Equity Ratio0.010.030.090.13
Long Term Debt-Equity Ratio0.000.000.040.12
Current Ratio1.451.341.191.15
Fixed Assets5.108.3214.8448.66
Inventory11.2326.9541.0079.53
Debtors4.346.726.3013.50
Interest Cover Ratio1789.0068.86163.33152.75
PBIDTM (%)19.7517.0214.118.97
PBITM (%)17.0615.1612.878.79
PBDTM (%)19.7416.8014.038.91
CPM (%)15.4412.9810.706.64
APATM (%)12.7511.139.476.47
ROCE (%)59.5983.91110.05236.36
RONW (%)45.3864.6388.94197.37

IMPORTANT LINKS

QUICK LINKS

FOR GRIEVANCE MAIL TO invgrieviss@iseindia.com

BSE EQUITIES : INB011077733 | NSE F&O EQUITIES : INF231077737 | NSE CASH MARKET : INB231077737 | NSE CURRENCY DERIVATIVES : INE231077737 | MCX-SX : INE261077737

ISS Enterprise Limited [Erstwhile: ISE Securities & Services Limited], a wholly owned subsidiary of Inter-connected Stock Exchange of India Ltd. (ISE)

© 2013 ISS Enterprise Limited [Erstwhile: ISE Securities & Services Limited]. All rights reserved.

Designed, developed & powered by C-MOTS Infotech (ISO 9001:2008 certified)